Agilent and PREMIER Biosoft Advance Lipidomics Research through Partnership
November 2nd 2012Agilent (California, USA) has announced the formation of a partnership with PREMIER Biosoft (California, USA). The partnership aims to aid the advancement of lipidomics research, by supporting integration of their respective software platforms allowing combination of data generation and processing. It is hoped that this will allow the mapping of complex lipidomic networks, advancing knowledge of lipid metabolism and diseases associated.
A Systematic Study of Achiral Stationary Phases Using Analytes with a Molecular Diversity Model
November 2nd 2012The authors characterized 12 SFC achiral stationary phases with 60 compounds from four chemical classes to establish guidelines for th rational selection of the optimum stationary phase for separations.
Increasing Column Efficiency with Slip Flow Technology
October 26th 2012The HPLC 2012 conference was abuzz with talk of "slip flow" following the talk given by Mary Wirth of Purdue University about her groundbreaking work involving protein column efficiency. In this interview, Wirth explains how “slip flow†works and what this discovery can contribute to the application of LC-MS to disease research.
Increasing Column Efficiency with Slip Flow Technology
October 26th 2012The HPLC 2012 conference was abuzz with talk of "slip flow" following the talk given by Mary Wirth of Purdue University about her groundbreaking work involving protein column efficiency. In this interview, Wirth explains how “slip flow†works and what this discovery can contribute to the application of LC-MS to disease research.
Research Partnership Between Shimadzu and the University of Texas at Arlington
October 26th 2012The University of Texas at Arlington (UT) (Texas, USA) has announced its investment of $7.5 million into the creation of the Institute for Research Technologies at UT Arlington, adding to the philanthropic investment made by Shimadzu (Duisburg, Germany) earlier this year.
Biomarker Disease Diagnosis Targeted by Thermo Fisher Scientific and Immunodiagnostik Collaboration
October 26th 2012Thermo Fisher Scientific (California, USA) has collaborated with Immunodiagnostik (Bensheim, Germany) to develop novel assays for the commercial qualitative and quantitative analysis of protein and peptide biomarkers in disease diagnosis
Biomarker Disease Diagnosis Targeted by Thermo Fisher Scientific and Immunodiagnostik Collaboration
October 26th 2012Thermo Fisher Scientific (California, USA) has collaborated with Immunodiagnostik (Bensheim, Germany) to develop novel assays for the commercial qualitative and quantitative analysis of protein and peptide biomarkers in disease diagnosis
Research Partnership Between Shimadzu and the University of Texas at Arlington
October 26th 2012The University of Texas at Arlington (UT) (Texas, USA) has announced its investment of $7.5 million into the creation of the Institute for Research Technologies at UT Arlington, adding to the philanthropic investment made by Shimadzu (Duisburg, Germany) earlier this year.